Literature DB >> 8355258

Ethyl substitution at the 7 position extends the half-life of 10-hydroxycamptothecin in the presence of human serum albumin.

T G Burke1, Z Mi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8355258     DOI: 10.1021/jm00069a020

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  8 in total

1.  3D superhydrophobic electrospun meshes as reinforcement materials for sustained local drug delivery against colorectal cancer cells.

Authors:  Stefan T Yohe; Victoria L M Herrera; Yolonda L Colson; Mark W Grinstaff
Journal:  J Control Release       Date:  2012-06-06       Impact factor: 9.776

2.  Injectable SN-38-loaded Polymeric Depots for Cancer Chemotherapy of Glioblastoma Multiforme.

Authors:  Chawan Manaspon; Norased Nasongkla; Khuanjit Chaimongkolnukul; Pinunta Nittayacharn; Ketpat Vejjasilpa; Kanchana Kengkoom; Atthaporn Boongird; Suradej Hongeng
Journal:  Pharm Res       Date:  2016-08-05       Impact factor: 4.200

3.  Stabilization of 10-hydroxycamptothecin in poly(lactide-co-glycolide) microsphere delivery vehicles.

Authors:  A Shenderova; T G Burke; S P Schwendeman
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

4.  Novel topoisomerase I-targeting antitumor agents synthesized from the N,N,N-trimethylammonium derivative of ARC-111, 5H-2,3-dimethoxy-8,9-methylenedioxy-5-[(2-N,N,N-trimethylammonium)ethyl]dibenzo[c,h][1,6]naphthyridin-6-one iodide.

Authors:  Wei Feng; Mavurapu Satyanarayana; Yuan-Chin Tsai; Angela A Liu; Leroy F Liu; Edmond J LaVoie
Journal:  Eur J Med Chem       Date:  2009-02-20       Impact factor: 6.514

5.  Photochemical properties of camptothecin in the presence of copper(II) ions: the role of radicals as prospective species in photodynamic therapy.

Authors:  Vlasta Brezová; Dana Dvoranová; Vladimír Zúbor; Martin Breza; Milan Mazúr; Marián Valko
Journal:  Mol Biotechnol       Date:  2007-09       Impact factor: 2.695

6.  A phase I study of 7-t-butyldimethylsilyl-10-hydroxycamptothecin in adult patients with refractory or metastatic solid malignancies.

Authors:  Susanne M Arnold; John J Rinehart; Eleftheria Tsakalozou; John R Eckardt; Scott Z Fields; Brent J Shelton; Philip A DeSimone; Bryan K Kee; Jeffrey A Moscow; Markos Leggas
Journal:  Clin Cancer Res       Date:  2010-01-12       Impact factor: 12.531

7.  11-Substituted 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridine derivatives as novel topoisomerase I-targeting agents.

Authors:  Wei Feng; Mavurapu Satyanarayana; Yuan-Chin Tsai; Angela A Liu; Leroy F Liu; Edmond J LaVoie
Journal:  Bioorg Med Chem       Date:  2008-08-07       Impact factor: 3.641

8.  12-Substituted 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridines as novel topoisomerase I-targeting antitumor agents.

Authors:  Wei Feng; Mavurapu Satyanarayana; Yuan-Chin Tsai; Angela A Liu; Leroy F Liu; Edmond J LaVoie
Journal:  Bioorg Med Chem       Date:  2009-02-20       Impact factor: 3.641

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.